David Matallanas

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Cancers

Small GTPases

PLoS computational biology

Open research Europe

University College Dublin

Universidad Autónoma de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College Dublin Jan 01 2020

Ireland

Assistant professor :: School of Medicine/Systems Biology Ireland

University College Dublin Aug 01 2011

Ireland

Research Fellow :: Systems Biology Ireland

University College Dublin Sep 01 2009 - Jul 31 2011

Ireland

Postdoctoral researcher :: Systems Biology Ireland

Beatson Institute for Cancer Research Jan 05 2005 - Aug 31 2009

United Kingdom

Postdoctoral fellow

Consejo Superior de Investigaciones Cientificas

Spain

Postgradute researcher :: Unidad asociada IIB-Universidad de Cantabria

Consejo Superior de Investigaciones Cientificas

Spain

PhD student :: Instituto de investigaciones biomedicas

Education History

Universidad Autónoma de Madrid Sep 20 1998 - Nov 28 2003

Spain

PHD :: School of medicine

Universidad de Alcalá de Henares Sep 22 1994 - Jul 01 1998

Spain

BSC :: Faculty of Sciences

Publications

Rebecca Sheridan, Kieran Brennan, Despina Bazou, Peter O'Gorman, David Matallanas, Margaret M Mc Gee
Multiple Myeloma Derived Extracellular Vesicle Uptake by Monocyte Cells Stimulates IL-6 and MMP-9 Secretion and Promotes Cancer Cell Migration and Proliferation. Cancers 16 (5) (2024)
Rebecca Sheridan, Kieran Brennan, Despina Bazou, Peter O'Gorman, David Matallanas, Margaret M Mc Gee
Multiple Myeloma Derived Extracellular Vesicle Uptake by Monocyte Cells Stimulates IL-6 and MMP-9 Secretion and Promotes Cancer Cell Migration and Proliferation. Cancers 16 (5) (2024)
Rebecca Sheridan, Kieran Brennan, Despina Bazou, Peter O'Gorman, David Matallanas, Margaret M Mc Gee
Multiple Myeloma Derived Extracellular Vesicle Uptake by Monocyte Cells Stimulates IL-6 and MMP-9 Secretion and Promotes Cancer Cell Migration and Proliferation. Cancers 16 (5) (2024)
Aoife Nolan, Cinzia Raso, Walter Kolch, Alexander von Kriegsheim, Kieran Wynne, David Matallanas
Proteomic Mapping of the Interactome of KRAS Mutants Identifies New Features of RAS Signalling Networks and the Mechanism of Action of Sotorasib. Cancers 15 (16) (2023)
Rebecca L Gorry, Kieran Brennan, Paul T M Lavin, Tayler Mazurski, Charline Mary, David Matallanas, Jean-François Guichou, Margaret M Mc Gee
Cyclophilin A Isomerisation of Septin 2 Mediates Abscission during Cytokinesis. International journal of molecular sciences 24 (13) (2023)
Husvinee Sundaramurthi, Valentina Tonelotto, Kieran Wynne, Fiona O'Connell, Eve O'Reilly, Marcel Costa-García, Csenger Kovácsházi, Ágnes Kittel, Simone Marcone, Alfonso Blanco, Eva Pallinger, Szabolcs Hambalkó, Jose Maria Piulats Rodriguez, Péter Ferdinandy, Jacintha O'Sullivan, David Matallanas, Lasse D Jensen, Zoltán Giricz, Breandán N Kennedy
Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes. Open research Europe 3 (2023)
Lucía García-Gutiérrez, Emma Fallahi, Nourhan Aboud, Niall Quinn, David Matallanas
Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner. Cell death & disease 13 (8) (2022)
David Romano, Lucía García-Gutiérrez, Nourhan K Aboud, David J Duffy, Keith T Flaherty, Dennie T Frederick, Walter Kolch, David Matallanas
Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma. Life science alliance 5 (10) (2022)
Niall P Quinn, Lucía García-Gutiérrez, Carolanne Doherty, Alexander von Kriegsheim, Emma Fallahi, David B Sacks, David Matallanas
IQGAP1 Is a Scaffold of the Core Proteins of the Hippo Pathway and Negatively Regulates the Pro-Apoptotic Signal Mediated by This Pathway. Cells 10 (2) (2021)
Christina Kiel, David Matallanas, Walter Kolch
The Ins and Outs of RAS Effector Complexes. Biomolecules 11 (2) (2021)
Aoife A Nolan, Nourhan K Aboud, Walter Kolch, David Matallanas
Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling. Genes 12 (4) (2021)
Lucía García-Gutiérrez, Stephanie McKenna, Walter Kolch, David Matallanas
RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy. Cancers 12 (1) (2020)
Susan A Kennedy, Mohamed-Ali Jarboui, Sriganesh Srihari, Cinzia Raso, Kenneth Bryan, Layal Dernayka, Theodosia Charitou, Manuel Bernal-Llinares, Carlos Herrera-Montavez, Aleksandar Krstic, David Matallanas, Max Kotlyar, Igor Jurisica, Jasna Curak, Victoria Wong, Igor Stagljar, Thierry LeBihan, Lisa Imrie, Priyanka Pillai, Miriam A Lynn, Erik Fasterius, Cristina Al-Khalili Szigyarto, James Breen, Christina Kiel, Luis Serrano, Nora Rauch, Oleksii Rukhlenko, Boris N Kholodenko, Luis F Iglesias-Martinez, Colm J Ryan, Ruth Pilkington, Patrizia Cammareri, Owen James Sansom, Steven Shave, Manfred Auer, Nicola Horn, Franziska Klose, Marius Ueffing, Karsten Boldt, David J Lynn, Walter Kolch
Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D. Nature communications 11 (1) (2020)
Vít Nováček, Gavin McGauran, David Matallanas, Adrián Vallejo Blanco, Piero Conca, Emir Muñoz, Luca Costabello, Kamalesh Kanakaraj, Zeeshan Nawaz, Brian Walsh, Sameh K Mohamed, Pierre-Yves Vandenbussche, Colm J Ryan, Walter Kolch, Dirk Fey
Accurate prediction of kinase-substrate networks using knowledge graphs. PLoS computational biology 16 (12) (2020)
Ana Herrero, Mariana Reis-Cardoso, Iñaki Jiménez-Gómez, Carolanne Doherty, Lorena Agudo-Ibañez, Adan Pinto-Fernandez, Fernando Calvo, Walter Kolch, Piero Crespo, David Matallanas
Characterisation of HRas local signal transduction networks using engineered site-specific exchange factors. Small GTPases 11 (5) (2018)

David Matallanas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Matallanas